Table 3:
Treatment strategy | Willingness-to-pay threshold | ||
---|---|---|---|
$50,000/QALY- gained |
$100,000/QALY- gained |
$150,000/QALY- gained |
|
One-year time horizon | |||
Unrestricted rifaximin access | $2.34 per pill $98.28 per treatment |
$3.53 per pill $148.26 per treatment |
$4.71 per pill $197.82 per treatment |
Formulary-restricted rifaximin access | $10.59 per pill $444.78 per treatment |
$18.46 per pill $775.32 per treatment |
$26.34 per pill $1,106.28 per treatment |
Five-year time horizon | |||
Unrestricted rifaximin access | $2.22 per pill $93.14 per treatment |
$3.45 per pill $145.10 per treatment |
$4.69 per pill $197.06 per treatment |
Formulary-restricted rifaximin access | $11.11 per pill $466.61 per treatment |
$19.15 per pill $804.21 per treatment |
$27.19 per pill $1,141.82 per treatment |